A CloudMD Company
x
Sign in Get IMD Health

Introducing IMD’s newest content partner Antiphospholipid Syndrome Foundation of America! 

APS Foundation of America and IMD Health Announce Partnership to Improve Quality of Patient Education

August 30, 2022 – Toronto, Ontario

IMD Health Global is pleased to announce an important new partnership with the Antiphospholipid Syndrome (APS) Foundation of America. This partnership will be invaluable to helping IMD Health in their commitment to providing easily accessible, up-to-date digital health education to healthcare providers, patients and their families on the IMD platform.

“The APSFA is excited to be working with IMD Health.  IT is a great opportunity to educate the community and patients about Antiphospholipid Syndrome (APS)”, said Christina (Tina) Pohlman, Founder of the APS Foundation of America, Inc.

IMD’s health education platform is one of the largest in North America, offering healthcare providers and patients instant access to graphics, videos and other educational resources spanning 6,000+ health topics. These resources facilitate meaningful dialogue between healthcare professionals and patients inside the examination room, at hospital bedsides and pharmacies, and during virtual consultations.

“We are very excited to be collaborating with the APS Foundation of America in order to provide our clinicians, patients and their families with trusted information on Antiphospholipid Syndrome” said Alice Haidau, Medical Content Manager, IMD, citing the need for inclusive, evidence-based health information, particularly given the shift toward digital tools incited by the pandemic, and internet use which often leads to misinformation.

The APS Foundation of America’s resources are now freely available on IMD Health. This means that IMD’s established healthcare provider network can send patients home with resource packages containing reliable APS information on disease understanding, treatment, and condition management.

 

About the APS Foundation of America

Founded in 2005, APS Foundation of America, Inc. (APSFA) is the only United States non-profit health agency dedicated to bringing national awareness to Antiphospholipid Syndrome (APS), the major cause of multiple miscarriages, thrombosis, young strokes and heart attacks. We are a volunteer run, community based 501(c)3 non-profit Public Charity organization and is dedicated to fostering and facilitating joint efforts in the areas of education, support, public awareness, research and patient services.  The APSFA’s Medical Advisory Team includes nationally & internationally recognized experts on Antiphospholipid Syndrome.

For more information about the APS Foundation of America, please visit:

https://apsfa.org/

Or contact Tina at apsfa@apsfa.org or call/text at 1+ 608-782-2626.

 

About IMD Health Global

IMD Health Global is a Toronto-based eHealth software development company, focused on innovating healthcare education. Since 2010, IMD has grown into Canada’s largest digital patient engagement platform. Centred “At The Point of Care” ®, healthcare professionals use IMD’s cloud-based platform (in clinic or virtual consults) to engage with their patients at a deeper level and optimize knowledge transfer surrounding a patient’s condition and treatment plan. This is done through the seamless integration of over 110,000 images, booklets, and video resources into an award-winning user interface that makes patient education both efficient and effective. At the end of a patient’s consult, a summary of all the discussed information can be emailed to the patient to review and continue their learning journey at home, improving their health literacy and adherence to their treatment plan. The IMD platform is utilized by over 16,400 practitioners (doctors, nurses and pharmacists) in clinics, hospitals, pharmacies, infusion clinics and homecare settings.

For more information about IMD Health Global, please visit www.IMDhealth.com and https://app.IMDhealth.com or contact Jared Sonnenberg, VP, at  jared.sonnenberg@IMDhealth.com.

IMD Health is a subsidiary of CloudMD Software & Services (TSXV: DOC).

 

About CloudMD Software & Services

CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes.                                                                                  Through CloudMD’s proprietary technology, the company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s business is separated into three main divisions: Clinics and Pharmacies, Digital Solution and Enterprise Health Solutions, the Company’s fastest growing division. CloudMD’s Enterprise Health Solutions Division has built a leading employer healthcare solutions, including its Comprehensive Integrated Health Services Platform, which offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.

CloudMD currently services a direct ecosystem of over 5,700 clinicians including, 1,800+ mental health practitioners, 1,600+ allied health professionals, 1,400+ doctors and nurses and covers 12 million individual lives across North America.

Are you a patient organization? Are you interested in getting your content on IMD?

Reach out to alice.haidau@imdhealth.com.